Carl Myers, MD
Family Medicine · Platte City, MONPI 1659342285
Payments from drug & device makers
Across 208 payments — averaging $23.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$781
- AstraZeneca$752
- Amgen$615
- Pfizer$433
- Lilly USA, LLC$284
- GSK$270
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,830100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $781 |
| AstraZeneca | 24 | $752 |
| Amgen | 22 | $615 |
| Pfizer | 31 | $433 |
| Lilly USA, LLC | 15 | $284 |
| GSK | 13 | $270 |
| Johnson & Johnson | 11 | $255 |
| AbbVie(2 entities) | 9 | $195 |
| Boehringer Ingelheim | 4 | $160 |
| Novo Nordisk | 9 | $142 |
| Phathom Pharmaceuticals, Inc. | 5 | $139 |
| Biohaven Pharmaceuticals, Inc. | 3 | $126 |
| Exact Sciences | 6 | $101 |
| Astellas Pharma US Inc | 4 | $95 |
| Sumitomo Pharma America, Inc. | 4 | $61 |
| Dexcom, Inc. | 3 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 4 | $48 |
| Sanofi Pasteur Inc. | 2 | $44 |
| Boston Scientific | 1 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Merck | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Tolmar, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Circassia Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$304
- Repatha$235
- FREESTYLE LIBRE 3$128
- AIRSUPRA$120
- FARXIGA$120
How this compares
$4,830 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 134 | $108,783 |
| MounjaroTirzepatide | 54 | $64,986 |
| OzempicSemaglutide | 38 | $48,693 |
| TrulicityDulaglutide | 35 | $41,550 |
| JardianceEmpagliflozin | 21 | $32,715 |
| XareltoRivaroxaban | 25 | $29,262 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 77 | $23,942 |
| FarxigaDapagliflozin Propanediol | 17 | $22,931 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $13,891 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 41 | $11,787 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $10,398 |
| GemtesaVibegron | 18 | $10,370 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 56 | $10,087 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $9,343 |
| Novolog FlexpenInsulin Aspart | 20 | $8,938 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $433 | $132,725211 claims |
| Lilly USA, LLCMounjaro, Trulicity | $284 | $106,53689 claims |
| Novo NordiskOzempic | $142 | $48,69338 claims |
| GSKArexvy, Anoro Ellipta, Shingrix, Arnuity Ellipta | $270 | $38,091115 claims |
| Boehringer IngelheimJardiance | $160 | $32,71521 claims |
| AstraZenecaFarxiga, Symbicort | $752 | $32,27334 claims |
| Johnson & JohnsonXarelto | $255 | $29,26225 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $61 | $10,37018 claims |
| AbbVieLinzess, Combigan | $195 | $9,35126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Platte City
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.